Factoryreasonable price of   147127-20-6high quality of  147127-20-6

Lonzeal Pharmaceuticals is drug manufacturer with China/WHO/FDA/ANVISA GMP certificates. We supply pharmaceutical products to esteemed customers globally with high quality, competitive price and good service.

LONZEAL Pharmaceuticals was founded in 2006 and has become a leading manufacturing company covering finished formulation, active pharmaceutical ingredients and advanced intermediates, where ICH guidelines have been strictly applied in the whole chain of R&D, manufacturing process and quality management.

LONZEAL is taking attentiveness and profession to build high quality products, and contributing to health and beautiful life for everyone in the world. The products and manufacturing site of Lonzeal have been approved and inspected by stringent drug authorities such as USFDA, WHO, China NMPA, Brazil ANVISIA and India DCGI, based on which, we have been supplying to esteemed customers globally in the past 15 years with regulatory compliance and good quality.

We have manufacturing site located in Hebei National Biomedical Industrial Zone, FPPs and APIs R&D Center of in Shijiazhuang Hi-tech Development Park, and the commercial office in Beijing, China.

Our current main products cover anti-virus, anti-depression and anti-neuropathic pain areas. Lonzeal has become one of the key manufacturers in the global supply of anti-HIV drugs and is providing support to the treatment need of over 4 Million patients each year worldwide.

Nucleoside antiviral drugs are artificially synthesized nucleotide analogs with simple chemical structure and easy modification and synthesis. They are the fastest-growing antiviral drugs. A series of new high-efficiency and low-toxic nucleoside analogs have been developed successively. Viral drugs have been or will be used in the treatment of HIV infection and HBV infection. Nucleoside analogs can be divided into purines and pyrimidines according to the type of drug structure, and are mainly divided into anti-reverse transcriptase (RT) virus drugs, anti-hepatitis virus drugs, anti-herpes virus drugs, and anti-other virus drugs according to drug action. Wait. 
Tenofovir is an acyclic nucleoside antiviral drug, which has the effect of inhibiting HBV multienzyme aggregation and HIV reverse transcriptase. Combine with natural deoxyribose substrates to inhibit viral polymerase, and to terminate the chain by inserting human DNA. It is the first nucleotide analogue approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV-1 infection. Tenofovir is a drug in the AIDS cocktail therapy. Studies have shown that it can effectively improve monkeys' ability to prevent immunodeficiency virus (similar to human HIV).